As of 19th Jun 2018, the number of securities in issue is 15,120,321,774. So far as the Company is aware, the percentage of securities not in public hands is 17.05%.

Director Shareholdings (as of 19 June 2018)

NameNumber of Ordinary Shares% of Issued CapitalNumber of OptionsExpiry Date
Mark Slade1760000000.0116123711723011-14-2020
Kelvin Harrison666666660.00446666666711-14-2020
David Rae50,000,0000.33%150,000,00011-14-2020

Concert Party Shareholdings (as of 19 June 2018)

NameNumber of Ordinary Shares% of Issued CapitalNumber of OptionsExpiry Date
Gavin Breeze**12540004620.08289999999999999--
Chris Chapman***202057440.0013000000000000002--
Neil Garner*164339850.0011146828402-27-2022
Mr and Mrs Miles Quitmann138681180.0009--
Tessa Ogden33676240.0002--

* The interest of Neil Garner include 2,000,000 Ordinary Shares held by his wife, Charissa Lynn Garner.
** The interest of Gavin Breeze include interests held directly or through White Angle Limited.
*** The interest of Chris Chapman is held directly or through MyBusinessFD.

Shareholder Profile (as of 19 June 2018)

NameNumber of Ordinary Shares% of Issued Capital
Peel Hunt35906017420.2375
Mr Gavin Breeze12540004620.08289999999999999
Hargreaves Lansdown Asset Mgt12446722790.08230000000000001
Mr James Leek7060000000.0467
Woodspeen Investment Mgt7027799860.04650000000000001
Barclays Wealth6489906480.0429
Share Centre Investment Mgt6424494120.0425
TD Direct Investing6220682100.041100000000000005
Location Sciences Group PLC Directors & Related Holdings6201291040.040999999999999995
Hargreave Hale7652191655.06%

Warrants (as of 19 June 2018)

Mike Staten holds 558,352,249 share warrants at an issue price of 0.1692 pence per share. These warrants can be exercised when the share price reaches 0.1692 pence per share. For comparison the share price at 31 August was 0.03 pence per share.

Barclays hold 5,863,021,931 at an issue price of 0.03 pence per share. This equates to 29.9% of the Company’s share capital, and were received in exchange for the release of the £2.5m loan facility. A Lock-in and Orderly Market Agreement (“LOMA”) was agreed. The warrants cannot be exercised for six months from the agreement (until 26 January 2018) without the prior written consent of the Company. A further provision was agreed where the warrants cannot be exercised for an additional six months (until 26th July 2018) other than through the Company’s Broker. In accordance with the terms of the loan redemption no funds are payable by Barclays on exercise of warrants.